We further revealed that PCK2-mediated gluconeogenesis removes abundance TCA cycle metabolites and restores redox balance in NSCLC cells upon glucose deprivation, showing the fine-tuning metabolic switches in cancer cells in response to nutrient-deprived tumor microenvironment. Here, PCK2 is linked to cancer.